Aardvark Therapeutics (AARD) announced the appointment of Derrick Li as Chief Business Officer, CBO, as well as the expansion of Nelson Sun’s role to include Chief Operating Officer, COO, in addition to his current role as Chief Financial Officer. The appointments are effective as of February 9, 2026.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AARD:
- Aardvark Expands PWS Phase 3 Trial to Younger Children
- Aardvark announces FDA submission, IRB approval of amended trial protocol
- Undervalued Obesity Innovator: Justifying a Buy on Aardvark’s Dual Rare-Disease and Mainstream Metabolic Opportunity
- Aardvark Therapeutics initiated with a Buy at B. Riley
- Ten new option listings and two option delistings on January 22nd